Dr. Shadwan F. Alsafwah, MD

Dr. Alsafwah practices at Advocate South Suburban Hospital - Mammography in Hazel Crest, Illinois.

Dr. Alsafwah's NPI, 1891890430, was assigned on September 14, 2006. Dr. Alsafwah holds Illinois license 036-098886.

Dr. Alsafwah's primary practice is Advocate South Suburban Hospital - Mammography, at 17800 S Kedzie Ave., Hazel Crest, IL 60429. The practice phone is (708) 213-3355.

Dr. Alsafwah's primary practice is Advocate South Suburban Hospital - Mammography in Hazel Crest, Illinois. Dr. Alsafwah is also affiliated with Advocate Christ Medical Center. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Alsafwah to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alsafwah practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Alsafwah's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Alsafwah's licenses on file in 3 states: Illinois, Arizona and Tennessee.

CMS data shows 4,416 Medicare services from Dr. Alsafwah across 15 procedure codes in 2024, for 2,700 Medicare patients. Medicare paid $86,049 for them.

CMS counts 2,700 Medicare patients who saw Dr. Alsafwah in 2024. The largest group is 65 to 74, with 936 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alsafwah's median patient age at 74, with 59% women.

In 2024, Dr. Alsafwah wrote 1,399 Medicare Part D claims for 231 patients. 76% of them were for generic drugs. CMS names the drug for 1,271 of them, across 23 drugs with 11 or more claims each, at $238,832 in total drug cost. In 2023, CMS named 907 claims across 23 drugs.

Dr. Alsafwah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of coronary angioplasty and stenting by Dr. Alsafwah, more than 37% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Alsafwah, published from 2013 to 2019. 2016 was the busiest year, with 3. The most frequent topics are Echocardiography, Coronary Angiography and Diagnosis, Differential. Dr. Alsafwah has published most often in Echocardiography. Dr. Alsafwah's most frequent co-authors are Smith Giri, Inyong Hwang and Rami Nadim Khouzam, MD.

CMS Open Payments shows 118 general payments to Dr. Alsafwah from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Medtronic, Inc. paid the most, $2,882.